Gita Erta

Dr. Gita Erta

Department of Human Physiology and Biochemistry, Riga Stradiņš University, Riga, Rīga, Latvia
orcid
PhD student

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
Salivary α-amylase, primarily encoded by the AMY1 gene, initiates the enzymatic digestion of dietary starch in the oral cavity and has recently emerged as a potential biomarker in metabolic research. Variability in salivary amylase activity (SAA), driven largely by copy number variation of AMY1, has been associated with postprandial glycemic responses, insulin secretion dynamics, and susceptibility to obesity. This review critically examines current analytical approaches for quantifying SAA, including enzymatic assays, colorimetric techniques, immunoassays, and emerging biosensor technologies. The methodological limitations related to sample handling, intra-individual variability, assay standardization, and specificity are highlighted in the context of metabolic and clinical studies. Furthermore, the review explores the physiological relevance of SAA in energy homeostasis and its associations with visceral adiposity and insulin resistance. We discuss the potential integration of SAA measurements into obesity risk stratification and personalized dietary interventions, particularly in individuals with altered starch metabolism. Finally, the review identifies key research gaps and future directions necessary to validate SAA as a reliable metabolic biomarker in clinical practice. Understanding the diagnostic and prognostic value of salivary amylase may offer new insights into the prevention and management of obesity and related metabolic disorders.

Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
The prevalence of overweight and obesity in women of reproductive age leads to significant health risks, including adverse metabolic and reproductive outcomes. Effective dietary interventions are critical to improving health outcomes in this population. This study investigates the impact of a 12-week diet intervention on metabolic markers of adipose tissue in overweight women of reproductive age, determining whether calorie restriction or low-starch diets are more effective, while also accounting for salivary amylase activity. A total of 67 overweight women of reproductive age were enrolled in a randomized controlled trial (RCT). Participants were divided into high-salivary-amylase (HSA) and low-salivary-amylase (LSA) groups based on baseline salivary amylase activity measured using a spectrophotometric method. Each group was further subdivided into two dietary intervention groups: calorie restriction (CR) and low starch (LS), resulting in four subgroups (HSA-CR, HSA-LS, LSA-CR, LSA-LS), along with a control group (CTR) of normal-weight individuals (no intervention). Participants were assigned to a calorie-restricted diet or a low-starch diet for 12 weeks. Key metabolic markers of adipose tissue, including insulin sensitivity, adipokines, cytokines, and lipid profiles, were measured at baseline (T0), 30 min after consuming starch-containing muesli (T1), and 12 weeks after intervention (T2). Active GLP-1, glucagon, and C-peptide levels were assessed to clarify the hormonal mechanisms underlying the dietary effects. Salivary amylase activity was also measured to examine its role in modulating glucose and GLP-1 responses. Both diet interventions led to significant improvements in metabolic markers of adipose tissue, though different ones. Calorie restriction improved insulin sensitivity by effectively reducing visceral fat mass and enhancing insulin signaling pathways. In contrast, the low-starch diet was linked to a reduction in the coefficient of glucose variation influenced partly by changes in GLP-1 levels. Our findings highlight the importance of personalized diet strategies to optimize metabolic health in this demographic.

Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
Butyrate, a short-chain fatty acid (SCFA) produced by the fermentation of dietary fibers in the colon, plays a pivotal role in regulating metabolic health, particularly by enhancing insulin sensitivity. Given the rising incidence of metabolic disorders, understanding the factors that influence butyrate production is of significant interest. This study explores the link between salivary amylase activity and butyrate levels in overweight women of reproductive age. Participants were categorized into low (LSA) and high (HSA) salivary amylase activity groups and further divided into two subgroups: one followed a low-starch diet (LS), and the other underwent caloric restriction (CR). We assessed salivary amylase activity and measured serum butyrate concentrations to examine their associations. Our findings showed a significant, though weak, positive correlation (ρ = 0.0486, p < 0.05), suggesting a link between salivary amylase activity and butyrate levels. The statistical significance, despite the weak correlation, implies that this relationship is not random. Moreover, higher baseline butyrate levels were observed in women with elevated salivary amylase activity. Also, women with low salivary amylase activity on a low-starch diet experienced a more pronounced increase in butyrate levels compared to those on caloric restriction. These results suggest that salivary amylase activity and dietary intake interact to influence butyrate production, with potential implications for improving insulin sensitivity and metabolic health. The study underscores the potential of butyrate in enhancing insulin sensitivity and promoting overall metabolic well-being. Further research is necessary to clarify the mechanisms involved and to understand the long-term effects of butyrate on metabolic health across different populations.

18 March 2025 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
PTPeteris Tretjakovs
Peteris Tretjakovs
Salivary amylase activity (SAA) is recognized as a potential biomarker for metabolic health. Previous studies suggest an association between SAA and insulin sensitivity, but the mechanisms remain unclear. This study investigates the relationship between SAA, visceral fat (VF), and the triglyceride-glucose (TyG) index to clarify the pathways linking SAA to metabolic risk factors. This cross-sectional study analysed data from women of reproductive age who were classified as overweight. Linear regression models were used to assess associations between salivary amylase activity (SAA), visceral fat (VF) and the triglyceride-glucose (TyG) index, while adjusting for confounding variables such as age, body mass index (BMI), physical activity and dietary patterns. Mediation analysis was conducted to determine whether VF mediates the relationship between SAA and the TyG index. Higher SAA was inversely associated with VF (β = -0.45, 95% CI: -0.65 to -0.25, p < 0.001). No direct association was observed between SAA and TyG index (β = -0.10, 95% CI: -0.25 to 0.05, p = 0.18) after adjustment for covariates. Mediation analysis revealed that visceral fat significantly mediated the relationship between SAA and the TyG index. The indirect effect of SAA on the TyG index through VF (A × B) was statistically significant (β = -0.16, 95% CI: -0.26 to -0.08), accounting for 45% of the total effect. These findings suggest that higher SAA may confer metabolic benefits by reducing VF, thereby indirectly influencing the TyG index. This highlights the critical role of VF in mediating the protective effects of SAA on metabolic health and provides insights into potential pathways for intervention.

21 October 2025 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Open access
Gita ErtaGita Erta
Gita Erta
GGGita Gersone
Gita Gersone
AJAntra Jurka
Antra Jurka
PTPēteris Tretjakovs
Pēteris Tretjakovs
This review examines the potential mechanisms by which SAA may influence glucose homeostasis and insulin sensitivity, emphasizing that current evidence is largely correlational and requires further investigation to establish causality. Salivary α-amylase (SAA), a key enzyme in the breakdown of dietary starch, has emerged as a potential regulator of glucose homeostasis, insulin secretion, and appetite control. Beyond its primary role in carbohydrate digestion, growing evidence highlights the influence of SAA on metabolic processes through its impact on early glucose release and its interaction with hormonal signaling pathways. This review examines the mechanisms by which SAA may affect insulin secretion and appetite regulation, focusing on its involvement in in incretin and other gut hormone-mediated pathways. Despite challenges posed by interindividual variability in SAA activity, its potential utility as a biomarker for metabolic health remains promising. Future research should prioritize uncovering the mechanistic links between SAA activity and metabolic outcomes, as well as establishing standardized protocols for its evaluation in both clinical and research contexts.

30 April 2026
Verified
Thesis
Open access
PDF file
Gita ErtaGita Erta
Gita Erta
This doctoral Thesis explores the role of salivary amylase activity (SAA) as a potential non-invasive biomarker of metabolic health by examining its associations with overweight status, visceral fat, and markers of glucose homeostasis, emphasising that current evidence is largely correlational and requires further investigation to establish causality. In a well-characterised cohort of overweight women of reproductive age, the crosssectional study, integrated as a foundational component of the interventional study, analysed associations between salivary amylase activity, visceral fat, and the triglyceride glucose index to establish baseline metabolic relationships, while the subsequent 12-week dietary intervention, stratified by salivary amylase activity levels, evaluated differential metabolic responses including changes in insulin sensitivity, GLP1 secretion, adipokines, and glucose homeostasis under calorie restricted and low starch diets, highlighting the potential of personalised nutrition in optimising metabolic health. The findings of this investigation were reported through three thematically aligned peerreviewed original research articles as well as two comprehensive review articles. A robust inverse relationship was observed between SAA and visceral adiposity, independent of total body fat, suggesting that higher SAA may be indicative of a metabolically healthier fat distribution phenotype. While visceral fat was positively correlated with the triglycerideglucose (TyG) index, a surrogate marker of insulin resistance, SAA exhibited no direct association with the TyG index. These findings support the hypothesis that SAA may influence glucose regulation indirectly, potentially through its modulation of fat accumulation and cephalic-phase insulin dynamics patterns rather than directly. While variability in SAA activity, largely driven by AMY1 gene copy number variation (CNV), also has been regulated by adrenergic activity, which can be partially modulated through lifestyle interventions. This is particularly relevant, as impaired autonomic regulation is commonly observed in individuals with obesity and metabolic syndrome and may be improved through targeted lifestyle changes. This potential responsiveness further supports its relevance as a candidate biomarker for metabolic plasticity. This Thesis proposes that SAA, as a non-invasive and easily measurable biomarker, could play a valuable role in the early identification of individuals at metabolic risk and in guiding personalised lifestyle interventions for the prevention of insulin resistance and obesityrelated complications. The Doctoral Thesis was developed at Rīga Stradiņš University, Department of Human Physiology and Biochemistry, Latvia. Defence of the Doctoral Thesis will take place at the public session of the Promotion Council of Basic Medicine on 27 April 2026, at 14.00 in the Hippocrates Lecture Theatre, 16 Dzirciema iela, Rīga Stradiņš University. 3.1. Basic Medicine; Sub-Sector – Normal Physiology. Keywords: salivary amylase activity; overweight; visceral fat; glucose homeostasis; insulin resistance; triglyceride-glucose index; metabolic health; cephalic-phase insulin secretion; dietary intervention.